Cas:70201-42-2 3,5-Dibromoisonicotinaldehyde manufacturer & supplier

We serve Chemical Name:3,5-Dibromoisonicotinaldehyde CAS:70201-42-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,5-Dibromoisonicotinaldehyde

Chemical Name:3,5-Dibromoisonicotinaldehyde
CAS.NO:70201-42-2
Synonyms:MFCD06410681;3,5-dibromopyridine-4-carbaldehyde;3,5-Dibromopyridine-4-carboxaldehyde
Molecular Formula:C6H3Br2NO
Molecular Weight:264.902
HS Code:2933399090

Physical and Chemical Properties:
Melting point:118-122ºC(lit.)
Boiling point:278.1±35.0 °C at 760 mmHg
Density:2.1±0.1 g/cm3
Index of Refraction:1.655
PSA:29.96000
Exact Mass:262.858124
LogP:2.51

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811
Packing Group:Ⅲ


Contact us for information like MFCD06410681 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,5-Dibromopyridine-4-carboxaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD06410681 Use and application,3,5-dibromopyridine-4-carbaldehyde technical grade,usp/ep/jp grade.


Related News: Nearly all patients who got the vaccine developed antibodies designed to head off the spread of abnormal tau while leaving healthy tau proteins intact, Novak said. 3,5-Dibromoisonicotinaldehyde manufacturer Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%. 3,5-Dibromoisonicotinaldehyde supplier This part is mainly anti-tumor drugs, prostate drugs and certain hormone drugs. 3,5-Dibromoisonicotinaldehyde vendor It was not clear which inquiry – the company’s or the government’s – was launched first and to what extent the subjects coincide. However, as Reuters reported last month, based on three sources familiar with the matter, the Justice Department’s investigation into Lilly includes a review of alleged manufacturing irregularities and records-tampering. 3,5-Dibromoisonicotinaldehyde factory Health Canada said it was planning an onsite inspection this summer and that it would not accept any product or ingredients made at the plant until the inspection was complete.